相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vasculotoxic Effects of Insulin and Its Role in Atherosclerosis: What is the Evidence?
Shailesh Nandish et al.
CURRENT ATHEROSCLEROSIS REPORTS (2011)
Studies on the Biotransformations and Biodistributions of Metal-Containing Drugs Using X-Ray Absorption Spectroscopy
Jade B. Aitken et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Chromium is not an essential trace element for mammals: effects of a low-chromium diet
Kristin R. Di Bona et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)
Imaging Metals in Proteins by Combining Electrophoresis with Rapid X-ray Fluorescence Mapping
Lydia Finney et al.
ACS CHEMICAL BIOLOGY (2010)
Overview of Newer Agents: Where Treatment Is Going
Ralph A. DeFronzo
AMERICAN JOURNAL OF MEDICINE (2010)
Oral Administration of the High-Chromium Yeast Improve Blood Plasma Variables and Pancreatic Islet Tissue in Diabetic Mice
Lu Liu et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2010)
Vanadium in the detection, prevention and treatment of cancer: The in vivo evidence
Anupam Bishayee et al.
CANCER LETTERS (2010)
Intramolecular Conversion of Pentaaquahydroperoxidochromium(III) Ion to Aqueous Chromium(V): Potential Source of Carcinogenic Forms of Chromium in Aerobic Organisms
Jack M. Carraher et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
Risks of Copper and Iron Toxicity during Aging in Humans
George J. Brewer
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
Current Concepts About Chromium Supplementation in Type 2 Diabetes and Insulin Resistance
Zhong Q. Wang et al.
CURRENT DIABETES REPORTS (2010)
Transport of Therapeutic Vanadium and Ruthenium Complexes by Blood Plasma Components
J. Costa Pessoa et al.
CURRENT MEDICINAL CHEMISTRY (2010)
The Cardiovascular Effects of Metformin: Further Reasons to Consider An Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus
Giovanni Anfossi et al.
CURRENT VASCULAR PHARMACOLOGY (2010)
Chromium: celebrating 50 years as an essential element?
John B. Vincent
DALTON TRANSACTIONS (2010)
Vanadium complexes having [(VO)-O-IV](2+) and [(VO2)-O-V](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities
Mannar R. Maurya et al.
DALTON TRANSACTIONS (2010)
Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands
Dachun Yao et al.
DIABETES (2010)
Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
Daniel J. Drucker et al.
DIABETES CARE (2010)
Sitagliptin A Review of its Use in the Management of Type 2 Diabetes Mellitus
Sohita Dhillon
DRUGS (2010)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
Evanthia Diamanti-Kandarakis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
The role of glimepiride in the treatment of type 2 diabetes mellitus
Vanessa J. Briscoe et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients
Andreas Holstein et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Discovery and development of selective PPAR-γ modulators (SPPAR-γMs) as safe and effective antidiabetic agents
Lalit S. Doshi et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Bromocriptine - unique formulation of a dopamine agonist for the treatment of type 2 diabetes
Richard Scranton et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase
Sally A. Madsen-Bouterse et al.
FREE RADICAL RESEARCH (2010)
Is Vanadate Reduced by Thiols under Biological Conditions? Changing the Redox Potential of V(V)/V(IV) by Complexation in Aqueous Solution
Debbie C. Crans et al.
INORGANIC CHEMISTRY (2010)
Fast Ligand Substitution at a Chromium(III) Hydroperoxo Complex
Wenjing Song et al.
INORGANIC CHEMISTRY (2010)
New Developments in the Comprehension of the Biotransformation and Transport of Insulin-Enhancing Vanadium Compounds in the Blood Serum
Daniele Sanna et al.
INORGANIC CHEMISTRY (2010)
Vanadium catalyzed oxidation with hydrogen peroxide
Valeria Conte et al.
INORGANICA CHIMICA ACTA (2010)
A Pilot Study of Chromium Picolinate for Weight Loss
Yuka Yazaki et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2010)
Dissecting the Mechanism of Insulin Resistance Using a Novel Heterodimerization Strategy to Activate Akt
Yvonne Ng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Supramolecular Protein Engineering DESIGN OF ZINC-STAPLED INSULIN HEXAMERS AS A LONG ACTING DEPOT
Nelson B. Phillips et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A quantitative study of the biotransformation of insulin-enhancing VO2+ compounds
Daniele Sanna et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
Investigation of the binding of Cr(III) complexes to bovine and human serum proteins: A proteomic approach
Cathy Tkaczyk et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2010)
Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus
Sunil Nair et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Vanadium K-edge XAS studies on the native and peroxo-forms of vanadium chloroperoxidase from Curvularia inaequalis
Rokus Renirie et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Inhibition of acid, alkaline, and tyrosine (PTP1B) phosphatases by novel vanadium complexes
Craig C. McLauchlan et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Spectroscopic analysis of the interaction between chromium (III) and apoovotransferrin
Yingqi Li et al.
JOURNAL OF LUMINESCENCE (2010)
Recent Advances in the Discovery of Competitive Protein Tyrosine Phosphatase 1B Inhibitors for the Treatment of Diabetes, Obesity, and Cancer
Andrew P. Combs
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Effects of Chromium Histidinate on Renal Function, Oxidative Stress, and Heat-Shock Proteins in Fat-Fed and Streptozotocin-Treated Rats
Ayhan Dogukan et al.
JOURNAL OF RENAL NUTRITION (2010)
Formation and Reactivity of Chromium(V)-Thiolato Complexes: A Model for the Intracellular Reactions of Carcinogenic Chromium(VI) with Biological Thio
Aviva Levina et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Presence of Surface Vanadium Peroxo-oxo Umbrella Structures in Supported Vanadium Oxide Catalysts: Fact or Fiction?
Julie E. Molinari et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Silicon nitride as a versatile growth substrate for microspectroscopic imaging and mapping of individual cells
Elizabeth A. Carter et al.
MOLECULAR BIOSYSTEMS (2010)
Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFκB, Akt, and Glut-2 in livers of zucker diabetic fatty rats
Sushil K. Jain et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus
William T. Cefalu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Inhibitory effect of CuSO4 on alpha-glucosidase activity in ddY mice
Yutaka Yoshikawa et al.
METALLOMICS (2010)
Metallo-allixinate complexes with anti-diabetic and anti-metabolic syndrome activities
Hiromu Sakurai et al.
METALLOMICS (2010)
A novel component of the metabolic syndrome: The oxidative stress
E. Hopps et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2010)
Improved cognitive-cerebral function in older adults with chromium supplementation
Robert Krikorian et al.
NUTRITIONAL NEUROSCIENCE (2010)
Biomedical applications of X-ray absorption and vibrational spectroscopic microscopies in obtaining structural information from complex systems
Jade B. Aitken et al.
RADIATION PHYSICS AND CHEMISTRY (2010)
Safety and toxicological evaluation of a novel chromium(III) dinicocysteinate complex
Nair Sreejayan et al.
TOXICOLOGY MECHANISMS AND METHODS (2010)
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes
Debora Williams-Herman et al.
BMC ENDOCRINE DISORDERS (2010)
Trace elements in glucometabolic disorders: an update
Nicolas Wiernsperger et al.
DIABETOLOGY & METABOLIC SYNDROME (2010)
Influence of metformin on GLUT1 gene and protein expression in rat streptozotocindiabetes mellitusmodel
Jelizaveta Sokolovska et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2010)
Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
Bo Ahren
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy (2010)
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
Seewoodhary et al.
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy (2010)
Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention
Badawi
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy (2010)
A newly synthetic chromium complex-Chromium (D-phenylalanine)3 activates AMP-activated protein kinase and stimulates glucose transport
Peng Zhao et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury
Suresh Varma Penumathsa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Cell biology of molybdenum
Ralf R. Mendel
BIOFACTORS (2009)
The Effects of Chromium Histidinate on Mineral Status of Serum and Tissue in Fat-Fed and Streptozotocin-Treated Type II Diabetic Rats
Ayhan Dogukan et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2009)
Mass Spectrometric and Spectroscopic Studies of the Nutritional Supplement Chromium(III) Nicotinate
Nicholas R. Rhodes et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2009)
The molecular structure of complexes formed by chromium or cobalt ions in simulated physiological fluids
Cathy Tkaczyk et al.
BIOMATERIALS (2009)
Impact of confinement and interfaces on coordination chemistry: Using oxovanadate reactions and proton transfer reactions as probes in reverse micelles
Debbie C. Crans et al.
COORDINATION CHEMISTRY REVIEWS (2009)
Clinical Utility of Acarbose, an α-Glucosidase Inhibitor in Cardiometabolic Disorders
Sho-ichi Yamagishi et al.
CURRENT DRUG METABOLISM (2009)
Use of Protein Tyrosine Phosphatase Inhibitors as Promising Targeted Therapeutic Drugs
P. Heneberg
CURRENT MEDICINAL CHEMISTRY (2009)
Iron absorption and metabolism
Gregory J. Anderson et al.
CURRENT OPINION IN GASTROENTEROLOGY (2009)
Goals of Treatment for Type 2 Diabetes β-Cell preservation for glycemic control
Piero Marchetti et al.
DIABETES CARE (2009)
Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes
Antonio Ceriello et al.
DIABETES CARE (2009)
Early Insulin Treatment in Type 2 Diabetes What are the pros?
Luigi F. Meneghini
DIABETES CARE (2009)
Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice
W. -Y. Chen et al.
DIABETES OBESITY & METABOLISM (2009)
Biodistribution of anti-diabetic Zn(II) complexes in human serum and in vitro protein-binding studies by means of CZE-ICP-MS
Anna K. Bytzek et al.
ELECTROPHORESIS (2009)
Are the effects of α-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?
Yoshihiko Suzuki et al.
FEBS LETTERS (2009)
Chronic toxicity and carcinogenicity studies of chromium picolinate monohydrate administered in feed to F344/N rats and B6C3F1 mice for 2 years
M. D. Stout et al.
FOOD AND CHEMICAL TOXICOLOGY (2009)
On the Transport of Vanadium in Blood Serum
Daniele Sanna et al.
INORGANIC CHEMISTRY (2009)
Treating type 2 diabetes: how safe are current therapeutic agents?
J. Philippe et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists
K. B. Hansen et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Structure, Properties, and Engineering of the Major Zinc Binding Site on Human Albumin
Claudia A. Blindauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Exploring the Chemistry and Biology of Vanadium-dependent Haloperoxidases
Jaclyn M. Winter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Interaction of VO2+ ion with human serum transferrin and albumin
Daniele Sanna et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands
Akira Katoh et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes
Maria Joao Pereira et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Decavanadate (V10O286-) and oxovanadates: Oxometalates with many biological activities
Manuel Aureliano et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Arylalkylamine vanadium salts as new anti-diabetic compounds
Antonio Zorzano et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Design of vanadium mixed-ligand complexes as potential anti-protozoa agents
Julio Benitez et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Speciation in aqueous vanadate-ligand and peroxovanadate-ligand systems
Andras Gorzsas et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Vanadium treatment of type 2 diabetes: A view to the future
Katherine H. Thompson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Chloro-substituted dipicolinate vanadium complexes: Synthesis, solution, solid-state, and insulin-enhancing properties
Jason J. Smee et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Zinc and diabetes - clinical links and molecular mechanisms
Judith Jansen et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
Chromium Picolinate Does Not Improve Key Features of Metabolic Syndrome in Obese Nondiabetic Adults
Nayyar Iqbal et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2009)
A perspective on the role of metals in diabetes: past findings and possible future directions
Jennifer A. Meyer et al.
METALLOMICS (2009)
Recent developments in ruthenium anticancer drugs
Aviva Levina et al.
METALLOMICS (2009)
Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species
Nava Bashan et al.
PHYSIOLOGICAL REVIEWS (2009)
Insulin resistance is a cellular antioxidant defense mechanism
Kyle L. Hoehn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Heavy metal ion-induced insulin-mimetic signaling
Anna Eckers et al.
REDOX REPORT (2009)
Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells
Phillip J. Bilan et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2009)
Effects of Acarbose on Proinsulin and Insulin Secretion and their Potential Significance for the Intermediary Metabolism and Cardiovascular System
Christoph Rosak et al.
CURRENT DIABETES REVIEWS (2009)
Effect of Vanadium on Insulin Sensitivity in Patients with Impaired Glucose Tolerance
Omar Jacques-Camarena et al.
ANNALS OF NUTRITION AND METABOLISM (2008)
Albumin as a zinc carrier: properties of its high-affinity zinc-binding site
Jin Lu et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Effects of pre- and postnatal exposure to chromium picolinate or picolinic acid on neurological development in CD-1 mice
Melissa M. Bailey et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2008)
Comparison of the potential for developmental toxicity of prenatal exposure to two dietary chromium supplements, chromium picolinate and [Cr3O(O2CCH2CH3)6(H2O)3]+, in mice
M. M. Bailey et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2008)
Metallomics and metalloproteomics
W. Shi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Chemical properties and toxicity of chromium(III) nutritional supplements
Aviva Levina et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Current state for the development of metallopharmaceutics and anti-diabetic metal complexes
Hiromu Sakurai et al.
CHEMICAL SOCIETY REVIEWS (2008)
Effects of vanadium-containing compounds on membrane lipids and on microdomains used in receptor-mediated signaling
Deborah A. Roess et al.
CHEMISTRY & BIODIVERSITY (2008)
Biospeciation of antidiabetic VO(IV) complexes
Tamas Kiss et al.
COORDINATION CHEMISTRY REVIEWS (2008)
Copper Transport Systems are Involved in Multidrug Resistance and Drug Transport
Tatsuhiko Furukawa et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Recent advances in the discovery and development of PTP-1B inhibitors
Steve Tam et al.
DRUGS OF THE FUTURE (2008)
Chromium (VI) induces insulin resistance in 3T3-L1 adipocytes through elevated reactive oxygen species generation
Xuemei Ge et al.
FREE RADICAL RESEARCH (2008)
Reactivity of chromium(III) nutritional supplements in biological media: An X-ray absorption spectroscopic study
Annie Nguyen et al.
INORGANIC CHEMISTRY (2008)
Isolation of a novel chromium(III) binding protein from bovine liver tissue after chromium(VI) exposure
Ryan L. Peterson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
被撤回的出版物: Antidiabetogenic effects of chromium mitigate Hyperinsulinemia-induced cellular insulin resistance via correction of plasma membrane cholesterol imbalance (Retracted article. See vol. 24, pg. 1308, 2010)
Emily M. Horvath et al.
MOLECULAR ENDOCRINOLOGY (2008)
A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus
D. M. Smith et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2008)
Antidiabetic Bis-Maltolato-OxoVanadium(IV): Conversion of inactive trans-to bioactive cis-BMOV for possible binding to target PTP-1B
Thomas Scior et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2008)
Reactivity of potential anti-diabetic molybdenum(VI) complexes in biological media: A XANES spectroscopic study
Aviva Levina et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2007)
Action mechanism of bis(allixinato)oxovanadium(IV) as a novel potent insulin-mimetic complex: regulation of GLUT4 translocation and FoxO1 transcription factor
Makoto Hiromura et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2007)
Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat
Hiroyuki Yasui et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2007)
Antidiabetic copper(II)-picolinate: Impact of the first transition metal in the metallopicolinate complexes
Naoko Yasumatsu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Long-term safety evaluation of a novel oxygen-coordinated niacin-bound chromium (III) complex
Michael Shara et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2007)
Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B
Seokjoon Lee et al.
MEDICINAL RESEARCH REVIEWS (2007)
Molecular mechanism of bis(maltolato)oxovanadium(IV)-induced insulin signaling in 3T3-L1 and IM9 cells: impact of dexamethasone
Shambhunath Bose et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2007)
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery
Sheng Zhang et al.
DRUG DISCOVERY TODAY (2007)
Chromium treatment has no effect in patients with type 2 diabetes in a western population - A randomized, double-blind, placebo-controlled trial
Nanne Kleefstra et al.
DIABETES CARE (2007)
Improvement of hyperglycaemia and metabolic syndromes in type 2 diabetic KKAy mice by oral treatment with [meso-tetrakis(4-sulfonatophenyl)porphyrinato]oxovanadium(IV)(4-) complex
Tapan Kumar Saha et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2007)
X-ray absorption and EPR spectroscopic studies of the biotransformations of chromium(VI) in mammalian cells. Is chromodulin an artifact of isolation methods?
Aviva Levina et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Oral insulin-mimetic compounds that act independently of insulin
Silvia Garcia-Vicente et al.
DIABETES (2007)
Zinc fluxes and zinc transporter genes in chronic diseases
Chiara Devirgiliis et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2007)
Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome - Implications for microbial killing
Christine C. Winterbourn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
X-ray fluorescence microprobe imaging in biology and medicine
Tatjana Paunesku et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes
Yusuke Adachi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Vanadium in diabetes: 100 years from Phase 0 to Phase I
Katherine H. Thompson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Clinical studies on chromium picolinate supplementation in diabetes mellitus - A review
C. Leigh Broadhurst et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2006)
Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats
Ming-Hoang Lai et al.
INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2006)
Enhancement of insulin signaling pathway in adipocytes by oxovanadium(IV) complexes
Wanny Basuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
On the fate of vanadate in human blood
Andras Gorzsas et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2006)
Improvement of diabetes, obesity and hypertension in type 2 diabetic KKAy mice by bis(allixinato)oxovanadium(IV) complex
Yusuke Adachi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Insulin-sensitizing and cholesterol-lowering effects of chromium (D-Phenylalanine)3
Xiaoping Yang et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial
Dee Pei et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: Studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes
Yusuke Adachi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Reactive oxygen species have a causal role in multiple forms of insulin resistance
N Houstis et al.
NATURE (2006)
Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes
TC Delgado et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2005)
Are vanadium compounds drugable?: Structures and effects of antidiabetic vanadium compounds:: A critical review
T Scior et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2005)
Fifteen years of dancing with vanadium
DC Crans
PURE AND APPLIED CHEMISTRY (2005)
Oral therapy of L-glutamic acid γ-monohydroxamate-vanadium (2:1) complex:: Improvement of blood glucose profile in different types of diabetic rodents
Y Shechter et al.
PURE AND APPLIED CHEMISTRY (2005)
Aqueous chemistry of the vanadiumIII (VIII) and the VIII-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats
P Buglyó et al.
INORGANIC CHEMISTRY (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
A highly potent insulin-mimetic zinc(II) complex with a Zn(S2O2) coordination mode:: Bis(1,6-dimethyl-3-hydroxy-5-methoxy-2-pentyl-1,4-dihydropyridine-4-thionato)zinc(II)
Y Adachi et al.
CHEMISTRY LETTERS (2005)
New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): Transport and biotransformation of insulin-enhancing vanadium pharmaceuticals
BD Liboiron et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats
BJ Clodfelder et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2005)
A newly synthetic chromium complex -: chromium(phenylalanine)3 improves insulin responsiveness and reduces whole body glucose tolerance
XP Yang et al.
FEBS LETTERS (2005)
Mechanistic studies of relevance to the biological activities of chromium
A Levina et al.
COORDINATION CHEMISTRY REVIEWS (2005)
Insulino-mimetic and anti-diabetic effects of vanadium compounds
AK Srivastava et al.
DIABETIC MEDICINE (2005)
Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes
RT Watson et al.
ENDOCRINE REVIEWS (2004)
A kinetic study on the distribution of Cu(II)-ions between albumin and transferrin
RA Lovstad
BIOMETALS (2004)
Recent advances in the nutritional biochemistry of trivalent chromium
JB Vincent
PROCEEDINGS OF THE NUTRITION SOCIETY (2004)
Solution structures of chromium(VI) complexes with glutathione and model thiols
A Levina et al.
INORGANIC CHEMISTRY (2004)
Effective control of glycemic status and toxicity in Zucker diabetic fatty rats with an orally administered vanadate compound
TA Clark et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2004)
Reduction of insulin-stimulated glucose uptake by peroxynitrite is concurrent with tyrosine nitration of insulin receptor substrate-1
T Nomiyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Stability and absorption of chromium and absorption of chromium histidinate complexes by humans
RA Anderson et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2004)
The power of vanadate in crystallographic investigations of phosphoryl transfer enzymes
DR Davies et al.
FEBS LETTERS (2004)
Biomimetic oxidation of chromium(III): Does the antidiabetic activity of chromium(III) involve carcinogenic chromium(VI)?
I Mulyani et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
The cellular fate of glucose and its relevance in type 2 diabetes
C Bouché et al.
ENDOCRINE REVIEWS (2004)
Pharmacokinetic study and trial for preparation of enteric-coated capsule containing insulinomimetic vanadyl compounds: Implications for clinical use
H Sakurai et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2004)
Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes
KH Thompson et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium);: unliganded vanadium (VO4) as the active component
KG Peters et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2003)
Interdomain zinc site on human albumin
AJ Stewart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Chromium picolinate for reducing body weight: Meta-analysis of randomized trials
MH Pittler et al.
INTERNATIONAL JOURNAL OF OBESITY (2003)
Sialoglycoprotein and carbohydrate complexes in chromium toxicity
R Codd et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
Pharmacokinetics of vanadium in humans after intravenous administration of a vanadium containing albumin solution
G Heinemann et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes
Y Shechter et al.
COORDINATION CHEMISTRY REVIEWS (2003)
Characterization of chromodulin by X-ray absorption and electron paramagnetic resonance spectroscopies and magnetic susceptibility measurements
L Jacquamet et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential
KH Thompson et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2003)
Chronic glucose-lowering effects of rosiglitazone and bis(ethylmaltolato)oxovanadium(IV) in ZDF rats
VG Yuen et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2003)
Vanadyl-thiazolidinedione combination agents for diabetes therapy
T Storr et al.
BIOCONJUGATE CHEMISTRY (2003)
Metvan: a novel oxovanadium(IV) complex with broad spectrum anticancer activity
OJ D'Cruz et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2002)
Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized
JE Weder et al.
COORDINATION CHEMISTRY REVIEWS (2002)
The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats
YJ Sun et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2002)
Structural basis for inhibition of protein tyrosine phosphatases by Keggin compounds phosphomolybdate and phosphotungstate
YS Heo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2002)
XANES spectroscopy: A promising tool for toxicology: A tutorial
KK Gunter et al.
NEUROTOXICOLOGY (2002)
In vivo distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement
DDD Hepburn et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2002)
Bis(maltolato)oxovanadium(IV) inhibits the activity of PTP1B in Zucker rat skeletal muscle in vivo
A Mohammad et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Insulin signalling and the regulation of glucose and lipid metabolism
AR Saltiel et al.
NATURE (2001)
The stability of the biomimetic cation triaqua-μ-oxohexapropionatotrichromium(III) in vivo in rats
AA Shute et al.
POLYHEDRON (2001)
Cr(VI) increases tyrosine phosphorylation through reactive oxygen species-mediated reactions
Y Qian et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
A vanadium/aspirin complex controlled release using a poly(beta-propiolactone) film. Effects on osteosarcoma cells
MS Cortizo et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2001)
Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty bats
MC Munoz et al.
DIABETES (2001)
Aqueous chemistry of ammonium (dipicolinato)oxovanadate(V): The first organic vanadium(V) insulin-mimetic compound
DC Crans et al.
INORGANIC CHEMISTRY (2000)
Permeability, cytotoxicity, and genotoxicity of Cr(III) complexes and some Cr(V) analogues in V79 Chinese hamster lung cells
CT Dillon et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2000)
Elucidating a biological role for chromium at a molecular level
JB Vincent
ACCOUNTS OF CHEMICAL RESEARCH (2000)
Design of vanadium compounds as insulin enhancing agents
KH Thompson et al.
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS (2000)
Is chromium a trace essential metal?
DM Stearns
BIOFACTORS (2000)
分享论文
